Salicylic acid

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of warts, including plantar warts, flat warts, common warts, and calluses.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area, including corns or warts, should be washed with warm water prior to treatment. After cleansing, the skin must be thoroughly dried.

To prepare the medication, the inner plug should be removed from the bottle. The brush must then be installed into the bottle cap, ensuring it is pressed tightly, followed by securely tightening the cap on the bottle.

Once prepared, the cap can be opened, and the brush should be dipped into the liquid. The liquid is to be applied directly to the wart or corn. After the initial application, the liquid will dry and form a mask. A second application of the liquid should be made once the first layer has dried.

This procedure may be repeated once or twice daily as necessary, continuing until the wart or corn is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn, due to the potential for irritation and adverse reactions. Additionally, individuals with known allergies to any of the product's ingredients should refrain from use to avoid allergic reactions. The product is also contraindicated in pregnant or breastfeeding individuals, as safety in these populations has not been established. Furthermore, application is not recommended on moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes, due to the risk of complications or exacerbation of existing conditions.

Warnings and Precautions

For external use only; it is imperative to avoid contact with the eyes and ingestion of the product. Children should utilize this product only under adult supervision to ensure safety. It is essential to keep the product out of reach of children to prevent accidental ingestion.

The liquid formulation is prone to volatilization and crystallization; therefore, it is crucial to securely tighten the cap after each use to maintain product integrity. Prolonged exposure to air should be avoided to prevent degradation of the product. Additionally, the product must be kept away from fire and flame due to its volatile nature.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised without delay.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may exacerbate potential adverse effects. Regular monitoring of relevant health parameters is recommended for these populations to ensure safe use.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only; it should not come into contact with the eyes or be ingested. Children must use this product under adult supervision to ensure safety.

It is crucial to keep the product out of reach of children and to avoid prolonged exposure to air during use, as the liquid can easily volatilize and crystallize. Additionally, users should ensure that the cap is tightly secured after each use and keep the product away from fire and flame to prevent any hazardous situations.

In clinical practice, if discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Drug Interactions

There are currently no documented drug interactions or laboratory test interactions associated with this medication. As such, no specific recommendations for dosage adjustments or monitoring are provided. Healthcare professionals should continue to exercise clinical judgment when prescribing this medication in conjunction with other therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remove. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication under the supervision of adults to ensure proper administration and monitoring. It is essential to keep the medication out of reach of children to prevent accidental ingestion or misuse.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and its safety profile in lactating women is also unclear. Therefore, healthcare professionals are advised to counsel women of childbearing potential regarding the importance of effective contraception during treatment and to discuss alternative therapeutic options for pregnant or breastfeeding patients.

Lactation

Lactating mothers are advised against the use of this medication while breastfeeding. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective recovery.

Nonclinical Toxicology

The use of this product is contraindicated in individuals who are pregnant or breastfeeding due to potential teratogenic effects. Currently, there is no available data regarding non-teratogenic effects. Additionally, there is no information provided in the nonclinical toxicology section, nor is there any data available pertaining to animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed to discontinue use and consult a healthcare professional if discomfort persists. Additionally, it is important to discuss the use of this product with patients who have diabetes or poor blood circulation, as these conditions may affect their safety and response to the product.

Healthcare providers should also instruct patients to avoid contact with the eyes, ears, and mouth while using the product. In case of accidental contact with the eyes, patients should rinse their eyes thoroughly with water.

Storage and Handling

There is currently no data available regarding the supply configurations or storage and handling conditions for this product.

Additional Clinical Information

The transdermal route of administration is indicated for the treatment, with the procedure to be repeated once or twice daily as needed until the wart is removed, for a duration of up to 12 weeks. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remove, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)